CA3223723A1 - Circulating microrna signatures for pancreatic cancer - Google Patents
Circulating microrna signatures for pancreatic cancer Download PDFInfo
- Publication number
- CA3223723A1 CA3223723A1 CA3223723A CA3223723A CA3223723A1 CA 3223723 A1 CA3223723 A1 CA 3223723A1 CA 3223723 A CA3223723 A CA 3223723A CA 3223723 A CA3223723 A CA 3223723A CA 3223723 A1 CA3223723 A1 CA 3223723A1
- Authority
- CA
- Canada
- Prior art keywords
- hsa
- seq
- mir
- quantifying
- specifically hybridizes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163220195P | 2021-07-09 | 2021-07-09 | |
| US63/220,195 | 2021-07-09 | ||
| PCT/US2022/036608 WO2023283476A2 (en) | 2021-07-09 | 2022-07-09 | Circulating microrna signatures for pancreatic cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3223723A1 true CA3223723A1 (en) | 2023-01-12 |
Family
ID=84801035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3223723A Pending CA3223723A1 (en) | 2021-07-09 | 2022-07-09 | Circulating microrna signatures for pancreatic cancer |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250092460A1 (enExample) |
| EP (1) | EP4367257A4 (enExample) |
| JP (1) | JP2024527370A (enExample) |
| AU (1) | AU2022306397A1 (enExample) |
| CA (1) | CA3223723A1 (enExample) |
| WO (1) | WO2023283476A2 (enExample) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014055117A1 (en) * | 2012-10-04 | 2014-04-10 | Asuragen, Inc. | Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions |
| CN105102637B (zh) * | 2013-04-17 | 2018-05-22 | Lg电子株式会社 | 提取胰腺癌诊断生物标志物的方法、用于该方法的计算装置、胰腺癌诊断生物标志物以及包含该生物标志物的胰腺癌诊断装置 |
| CA3018048A1 (en) * | 2016-03-31 | 2017-10-05 | Toray Industries, Inc. | Kit or device for detecting early stage pancreatic cancer or pancreatic cancer precursor lesions and detection method therefor |
| WO2018129535A1 (en) * | 2017-01-09 | 2018-07-12 | Dana-Farber Cancer Institute, Inc. | Circulating microrna signatures for ovarian cancer |
| BR102018003587A2 (pt) * | 2018-02-23 | 2020-07-07 | Onkos Diagnósticos Moleculares Ltda Me | método e kit para detecção de tipo de tumor de tireoide |
| CN109055557B (zh) * | 2018-09-11 | 2022-11-29 | 朱伟 | 一种与胰腺癌辅助诊断相关的血清miRNA标志物及其应用 |
-
2022
- 2022-07-09 WO PCT/US2022/036608 patent/WO2023283476A2/en not_active Ceased
- 2022-07-09 US US18/577,387 patent/US20250092460A1/en active Pending
- 2022-07-09 CA CA3223723A patent/CA3223723A1/en active Pending
- 2022-07-09 EP EP22838508.4A patent/EP4367257A4/en active Pending
- 2022-07-09 AU AU2022306397A patent/AU2022306397A1/en active Pending
- 2022-07-09 JP JP2024500606A patent/JP2024527370A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024527370A (ja) | 2024-07-24 |
| AU2022306397A1 (en) | 2024-01-25 |
| WO2023283476A2 (en) | 2023-01-12 |
| WO2023283476A3 (en) | 2023-03-09 |
| EP4367257A2 (en) | 2024-05-15 |
| US20250092460A1 (en) | 2025-03-20 |
| WO2023283476A9 (en) | 2023-11-23 |
| EP4367257A4 (en) | 2025-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7466157B2 (ja) | 膵臓がんの検出キット又はデバイス及び検出方法 | |
| US12385099B2 (en) | Circulating microrna signatures for ovarian cancer | |
| JP7706728B2 (ja) | 胆道がんの検出キット又はデバイス及び検出方法 | |
| US20230227914A1 (en) | Biomarkers of oral, pharyngeal and laryngeal cancers | |
| JP2019122412A (ja) | Ｍｉｒｎａ比率を使用する肺がん決定 | |
| US11661633B2 (en) | Methods for predicting prostate cancer and uses thereof | |
| JP6611411B2 (ja) | 膵臓がんの検出キット及び検出方法 | |
| US20240254566A1 (en) | Analysis method, kit, and detection device | |
| US20250092460A1 (en) | Circulating microrna signatures for pancreatic cancer | |
| JP2015139440A (ja) | 胆管がんの検出キット及び検出方法 | |
| CN114746551A (zh) | 大肠癌诊断用标志物、辅助大肠癌的诊断的方法、收集数据以用于大肠癌诊断的方法、大肠癌的诊断试剂盒、大肠癌治疗药物、大肠癌的治疗方法、大肠癌的诊断方法 | |
| WO2025105011A1 (en) | Method for determining pancreatic cancer | |
| Liu et al. | Identification of Key Genes and Pathways Associated with Adriamycin Resistance in Breast Cancer | |
| CN108531571A (zh) | 用于检测注意力缺陷/过动症的方法和试剂盒 | |
| WO2025217467A1 (en) | Occult blood mrna biomarkers paired with dna/rna mutations and dna methylation | |
| US20250298015A1 (en) | Diagnostic method of detecting inflammation biomarker(s) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD Year of fee payment: 2 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250707 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250707 |